About: In response to the letter of Montagud‐Marrahi et al.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: In response to the letter of Montagud‐Marrahi et al. Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	In response to the letter of Montagud‐Marrahi et al.
Creator	Darmon, Michael Dupont, Thibault Fodil, Sofiane Marcault, Clémence
Source	Medline; PMC
abstract	We read with interest the correspondence from Montagud‐Marrahi et al. putting forward that solid organ transplant (SOT) recipients are not at higher risk of severe COVID‐19 infection despite their immunosuppression and the mild or atypical nature of their symptoms in their Spanish cohort. In the recent literature, this population achieves a mortality rate between 20% and 52% when they become critically ill. Moreover, as innate immunity is altered by the infection, decreased doses of immunosuppressive drugs should be considered.
has issue date	2020-06-08(xsd:dateTime)
bibo:doi	10.1111/ajt.16126
bibo:pmid	32515045
has license	no-cc
sha1sum (hex)	920e78931123b7d27bed2b232b3732b3561c3dd0
schema:url	https://doi.org/10.1111/ajt.16126
resource representing a document's title	In response to the letter of Montagud‐Marrahi et al.
has PubMed Central identifier	PMC7300947
has PubMed identifier	32515045
schema:publication	Am J Transplant
resource representing a document's body	covid:920e78931123b7d27bed2b232b3732b3561c3dd0#body_text
is schema:about of	named entity 'COVID-19' named entity 'atypical' named entity 'cohort' named entity 'solid organ transplant' named entity 'organ transplantation' named entity 'immunocompromised patients' named entity 'COVID' named entity 'immunosuppression' named entity 'inflammation' named entity 'American Journal of Transplantation' named entity 'critically ill' named entity '40%' named entity '20%' named entity 'Solid organ transplant' named entity 'mortality rate' named entity 'diabetes' named entity 'immunosuppressive drugs' named entity 'total lymphocyte count' named entity 'hypoxemic' named entity 'Saint-Louis hospital' named entity 'COVID' named entity 'respiratory failure' named entity 'critically ill' named entity 'innate immunity' named entity 'lymphocytopenia' named entity 'ICU' named entity 'COVID' named entity 'comorbidities' named entity 'COVID' named entity 'kidney' named entity 'infection' named entity '3,5' named entity 'Paris' named entity 'asthenia' named entity 'fever' named entity 'tested positive for COVID-19' named entity 'hypertension' named entity 'COVID' named entity 'infection' named entity 'SOT' named entity 'immunosuppression' named entity 'higher risk' named entity 'organ transplant' named entity 'SOT' named entity 'Spanish' named entity 'nature' named entity 'immunosuppression' named entity 'symptoms' named entity 'mild' named entity 'risk' named entity 'read' named entity 'higher' named entity 'infection' named entity 'correspondence'
is part of of	We read with interest the correspondence from Montagud‐Marrahi et al. putting forward that solid organ transplant (SOT) recipients are not at higher risk of severe COVID‐19 infection despite their immunosuppression and the mild or atypical nature of their symptoms in their Spanish cohort. In the recent literature, this population achieves a mortality rate between 20% and 52% when they become critically ill. Moreover, as innate immunity is altered by the infection, decreased doses of immunosuppressive drugs should be considered. covid:920e78931123b7d27bed2b232b3732b3561c3dd0#body_text In response to the letter of Montagud‐Marrahi et al.

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software